Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02IWH
|
||||
| Former ID |
DNC004253
|
||||
| Drug Name |
F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-COOH
|
||||
| Indication | Discovery agent | Investigative | [526456] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C80H131N27O22
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O<br />)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)N(C)C(=O)<br />C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C<br />NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)<br />C(CC2=CC=CC=C2)N
|
||||
| InChI |
1S/C80H131N27O22/c1-42(2)34-55(73(123)96-44(4)66(116)103-57(37-60(85)111)74(124)102-54(78(128)129)28-29-59(84)110)104-71(121)50(24-14-16-30-81)100-70(120)53(27-19-33-91-80(88)89)99-67(117)45(5)107(7)77(127)58(41-108)105-72(122)51(25-15-17-31-82)101-69(119)52(26-18-32-90-79(86)87)98-65(115)43(3)95-62(113)40-94-76(126)64(46(6)109)106-75(125)56(36-48-22-12-9-13-23-48)97-63(114)39-92-61(112)38-93-68(118)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,108-109H,14-19,24-41,81-83H2,1-7H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,118)(H,94,126)(H,95,113)(H,96,123)(H,97,114)(H,98,115)(H,99,117)(H,100,120)(H,101,119)(H,102,124)(H,103,116)(H,104,121)(H,105,122)(H,106,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1
|
||||
| InChIKey |
MJZVYHXPHQEPQQ-FKPOJLNCSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Nociceptin receptor | Target Info | Inhibitor | [526456] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.